1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797386840456560640 |
|---|---|
| author | Per thor Straten Ralf Wagner Peter Holst Louise Turner Amaia V Bermejo Isabella Skandorff Lasse Neukirch Jasmin Gille Frederik O Bagger Karen N Nielsen Joana Daradoumis Charlie R Ince Lara Duvnjak Mikkel D Müller Silke Schrödel Kaare Grunddal Kristoffer Staahl Rohrberg Christian Thirion Anne-Marie Andersson Emeline Ragonnaud |
| author_facet | Per thor Straten Ralf Wagner Peter Holst Louise Turner Amaia V Bermejo Isabella Skandorff Lasse Neukirch Jasmin Gille Frederik O Bagger Karen N Nielsen Joana Daradoumis Charlie R Ince Lara Duvnjak Mikkel D Müller Silke Schrödel Kaare Grunddal Kristoffer Staahl Rohrberg Christian Thirion Anne-Marie Andersson Emeline Ragonnaud |
| author_sort | Per thor Straten |
| collection | DOAJ |
| first_indexed | 2024-03-08T22:15:14Z |
| format | Article |
| id | doaj.art-6005f92247f24444a2644dd3773cfafa |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-08T22:15:14Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-6005f92247f24444a2644dd3773cfafa2023-12-19T02:15:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 210.1136/jitc-2023-SITC2023.1147-F1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteinsPer thor Straten0Ralf Wagner1Peter Holst2Louise Turner3Amaia V Bermejo4Isabella Skandorff5Lasse Neukirch6Jasmin Gille7Frederik O Bagger8Karen N Nielsen9Joana Daradoumis10Charlie R Ince11Lara Duvnjak12Mikkel D Müller13Silke Schrödel14Kaare Grunddal15Kristoffer Staahl Rohrberg16Christian Thirion17Anne-Marie Andersson18Emeline Ragonnaud191National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark2University of Regensburg, Regensburg, Bayern, Germany1HERVOLUTION Therapeutics, COPENHAGEN, Greater Copenhagen, Denmark5University of Copenhagen, Copenhagen, Greater Copenhagen, Denmark1HERVOLUTION Therapeutics, COPENHAGEN, Greater Copenhagen, Denmark1HERVOLUTION Therapeutics, COPENHAGEN, Greater Copenhagen, Denmark1HERVOLUTION Therapeutics, COPENHAGEN, Greater Copenhagen, Denmark2University of Regensburg, Regensburg, Bayern, Germany3Rigshospitalet, Copenhagen, Greater Copenhagen, Denmark4HERVOLUTION Therapeutics, Copenhagen, Greater Copenhagen, Denmark4HERVOLUTION Therapeutics, Copenhagen, Greater Copenhagen, Denmark4HERVOLUTION Therapeutics, Copenhagen, Greater Copenhagen, Denmark5University of Copenhagen, Copenhagen, Greater Copenhagen, Denmark4HERVOLUTION Therapeutics, Copenhagen, Greater Copenhagen, Denmark6Perkin Elmer, Munich, Bayern, Germany5University of Copenhagen, Copenhagen, Greater Copenhagen, Denmark8Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark6Perkin Elmer, Munich, Bayern, Germany9InProTher, Copenhagen, Greater Copenhagen, Denmark4HERVOLUTION Therapeutics, Copenhagen, Greater Copenhagen, Denmark |
| spellingShingle | Per thor Straten Ralf Wagner Peter Holst Louise Turner Amaia V Bermejo Isabella Skandorff Lasse Neukirch Jasmin Gille Frederik O Bagger Karen N Nielsen Joana Daradoumis Charlie R Ince Lara Duvnjak Mikkel D Müller Silke Schrödel Kaare Grunddal Kristoffer Staahl Rohrberg Christian Thirion Anne-Marie Andersson Emeline Ragonnaud 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins Journal for ImmunoTherapy of Cancer |
| title | 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins |
| title_full | 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins |
| title_fullStr | 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins |
| title_full_unstemmed | 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins |
| title_short | 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins |
| title_sort | 1147 f human endogenous retrovirus k proteins form vlps with dense envelope incorporation explaining herv k immunogenicity in patients and yielding a tool for breaking tolerance to herv envelope proteins |
| work_keys_str_mv | AT perthorstraten 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT ralfwagner 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT peterholst 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT louiseturner 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT amaiavbermejo 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT isabellaskandorff 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT lasseneukirch 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT jasmingille 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT frederikobagger 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT karennnielsen 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT joanadaradoumis 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT charlierince 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT laraduvnjak 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT mikkeldmuller 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT silkeschrodel 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT kaaregrunddal 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT kristofferstaahlrohrberg 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT christianthirion 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT annemarieandersson 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins AT emelineragonnaud 1147fhumanendogenousretroviruskproteinsformvlpswithdenseenvelopeincorporationexplaininghervkimmunogenicityinpatientsandyieldingatoolforbreakingtolerancetohervenvelopeproteins |